According to a new report Global Veterinary Oncology Market, published by KBV research, The Global Veterinary oncology Market size is expected to reach $369.2 Million by 2026, rising at a market growth of 13.2% CAGR during the forecast period.
The COVID-19 outbreak has raised questions about potential medical supply problems, including both pharmaceutical and medical supplies such as personal protective equipment (PPE, e.g., gloves, masks, gowns) and surgical drapes. Veterinary clinics have reported limitations on filling orders or shortages of certain medical supplies (e.g., masks, gloves). And, governments are demanding that all healthcare practitioners, including veterinarians, delay elective procedures to preserve PPE and medical supplies.
The Chemotherapy segment had the largest market share in 2019 attributable to an increasing number of chemotherapeutic procedures introduced by surgeons attributable to their various advantages. Chemotherapy is a widely used modality of diagnosis for veterinary oncology in veterinary cancer medicine, according to AAHA's oncology recommendations in 2016.
Due to the high incidence of cancer in the canine population and rising life expectancy, canine accounted for the highest market share of the year 2019. Moreover, with a growing number of clinical trials on canine as a biological model, the increasing incidence of cancer in this community has further engaged researchers to conduct comparative veterinary oncology treatments.
The segment of lymphoma cancer type accounted for the largest share of revenue in 2019 due to the growing number of pet populations affected by the disease, especially canine ones. Mast cell cancer is followed by lymphoma along with mammalian and squamous cell cancer. Increasing incidence of mast cell cancer in dogs is expected to further fuel growth in the market.
North America is expected to lead the market growth over the forecast period. Growing focus on pet health, the involvement of a large number of pet drug suppliers, and the rapid introduction of innovative pet care drugs are key factors contributing to market growth. Moreover, an increasing amount of government funds for pet oncology care in this area and the involvement of market giants in the oncology sector are also driving the market growth.
Structural Insights: https://www.kbvresearch.com/veterinary-oncology-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Boehringer Ingelheim International GmbH, Karyopharm Therapeutics, Inc., Regeneus Ltd., Elanco Animal Health, Inc., Zoetis, Inc., Varian Medical Systems, Inc., PetCure Oncology, LLC (Accelitech, LLC), AB Science SA, Rhizen Pharmaceuticals S.A., and Nippon Zenyaku Kogyo Co., Ltd.
By Animal Type
By Therapy
By Cancer Type
By Geography
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
